$68,359,693
to PFIZER INC
IGF::OT::IGF
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Pfizer contract with HHS ASPR for vaccine or therapeutic development and pandemic preparedness support.
ASPR contracts with major pharma manufacturers are critical to U.S. pandemic response capacity and medical countermeasure stockpiling strategy.
Large Pfizer award signals continued government investment in domestic pharmaceutical manufacturing and cold-chain distribution capabilities.
U.S. securing domestic vaccine/therapeutic production capacity reduces dependence on foreign supply chains amid biotech competition with China.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002146.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_HHSO100201500029C_7505_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.